Erratum to "Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: Experience from an Indian center" [Clinica Chimica Acta 371 (2006) 183-186] (DOI:10.1016/j.cca.2006.02.038);Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: Experience from an Indian center

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 183-186

  Saini, Nitin ^a   Bhagat, Ashish ^a   Sharma, Sanjeev ^a   Duseja, Ajay ^a   Chawla, Yogesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alpha fetoprotein; Hepatitis B virus; Hepatocellular carcinoma; Portal vein thrombosis

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; TAMOXIFEN;

ABDOMINAL PAIN; ADULT; AGED; ALCOHOLISM; ANAMNESIS; ANOREXIA; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; ENDOSCOPY; FEMALE; FEVER; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; IMAGING; JAUNDICE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MEDICAL EXAMINATION; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; SCREENING; SMOKING; TUMOR VOLUME; ULTRASOUND; VARICOSIS; WEIGHT REDUCTION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33746780015     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.09.007     Document Type: Erratum

References (18)

1. Ferlay J, Bray F, Pisani P, and Parkin DMJ. GLOBOCAN 2000; Cancer incidence, mortality and prevalence worldwide, version 1.0, IARC cancer base No. 5 (Lyon, IARC Press, 2001).
2. Bosch F.X. Global epidemiology of hepatocellular carcinoma. In: Okuda K., and Tabor E. (Eds). Liver cancer (1997), Churchill Livingstone, New York 13-27
3. Mohandas K.M., and Vinay D. Epidemiology of hepatocellular carcinoma in India. In: Sarin S.K., and Okuda K. (Eds). Hepatitis B and C: carrier to cancer (2002), Harcourt Publishers 279-288
4. Sanjay K., Dash B.C., Thakur V., Guptan R.C., Sarin S.K., and Das B.C. p53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer 88 (2000) 1565-1573
5. Feitelson M.A., and Duan L.X. Hepatitis B virus antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 150 (1997) 1141-1157
6. Takano, Yokosuka O., Imazeki F., et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21 (1995) 650-655
7. Shiratori Y., Shuichiro S., Imamura M., et al. Characteristics difference of hepatocellular carcinoma between hepatitis B and C viral infection in Japan. Hepatology 22 (1995) 1027-1033
8. Zhang J.Y., Dai M., Wang X., et al. A case controlled study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 27 (1998) 374-378
9. Sarin S.K., Thakur V., Guptan R.C., et al. Profile of hepatocellular carcinoma in India. An insight into the possible etiologic associations. J Gastroenterol Hepatol 16 (2001) 666-673
10. Kew M.C., and Geddes E.W. Hepatocellular carcinoma in rural southern African blacks. Medicine (Baltimore) 61 (1982) 98-108
11. Merican I., Guan R., Amarapurkar D., et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15 (2000) 1356-1361
12. Idelman R., De Maria N., Colantoni A., and Van Thiel D.H. Pathogenesis of hepatitis B and C induced hepatocellular carcinoma. J Viral Hepat 5 (1998) 285-290
13. Austin H., Delze L.L.E., Grufferman S., et al. A case controlled study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking and alcohol consumption. Cancer Res 46 (1986) 962-966
14. Hardell L., Bengtsson N.O., Jonsson U., Eriksson S., and Larson L.G. Etiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria. An epidemiological investigation. Br J Cancer 50 (1984) 389-397
15. Paterlini P., Driss F., Nalpas B., et al. Persistence of hepatitis B and C viral genomes in primary liver cancers from HBsAg negative patients: a study of a low endemic area. Hepatology 17 (1993) 20-29
16. Oka H., Tomori A., Kuroki T., Kobayashi K., and Yamamoto S. Prospective study of alpha-fetoprotein in cirrhosis patients monitored for development of hepatocellular carcinoma. Hepatology 19 (1994) 61-66
17. Sato Y., Nakata K., Kato Y., et al. Early recognition of HCC based on altered profiles of alpha-fetoprotein. N Eng J Med 328 (1993) 1802-1806
18. Nomura F., Ohnishi K., and Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients. Cancer 64 (1989) 1700-1707